The Column Group — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Ribon TherapeuticsinDec 2022SEC filingmedium confidence
BiotechLexington, US
Victoria M. Richon(Executive Officer, Director)
BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)
Board seatJeff Goater· per SEC Form D · $25M raise · filed Dec 2022
Co-investorsAvego BioScience CapitalOUP (Osage University Partners)Peregrine VenturesAbbVieNovartis Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.